Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Covalon Technologies Ltd V.COV

Sector: Healthcare | Sub-Sector: Biotechnology
Alternate Symbol(s):  CVALF

Covalon Technologies Ltd is engaged in the business of developing, licensing, and selling medical technologies. The Company's segments are Advanced Wound Care and Specialized Medical Device Coatings.
Price: $1.30 | Change: $-0.10 | %Change: -7.14%
Volume: 35,330 | Day High/Low: 1.48/1.30 | 52 Week High/Low: 2.98/1.04
View modes: 
0 stars

RE:RE:RE:RE:RE:A licensing deal would go a long way right now

Yes and now it's down to $1.50... I still would like to know  why they needed  the additonal leased space?.... More production..more sales??  What ?? G1945V  rate and reply
5 stars

RE:RE:RE:RE:A licensing deal would go a long way right now

the consolidation was done when the share price was at 3 cents(converted to 30 cents after the 1:10).  Then it went from 30 cents to 3.00 after the consolidation so your statement is not correct.  rate and reply
0 stars

D&D

D&D seems to be buying up this stock every time it is week. Interesting, may be they are doing a financing and have to get the stock up to a certain price. Odd they would go to a shop like D&D. Not...read more
0 stars

RE:RE:RE:A licensing deal would go a long way right now

That paper you quoted is a joke and written by the chief scientific officer of the company. No clinically oriented surgeon would ever place much value in this white paper. These guys to have validity...read more
5 stars

RE:RE:A licensing deal would go a long way right now

Your argument makes no sense. Surgical site infections are the most common Healthcare Associate Infectin (HAI) (1) and you are saying that the current practice of using Chloraprep is adequate?  Well...read more
3 stars

RE:A licensing deal would go a long way right now

The new product did not get traction because it does not make sense. There is no OR that does not prep with Chloraprep.... I don't see this product as having legs. Standard for these guys to do a...read more
0 stars

A licensing deal would go a long way right now

Need another catalyst to get the share price moving up. New product launch didn't seem to do much. It's been 15-16 months since deal with Molnlycke and nothing since then. I hope they have more than...read more
0 stars

RE:Expansion of their leased space

Based on the Realtor's posting outside building and the annual lease cost of $159,250.00(per year for the first 5) the new facilities space would be approx 12K sq ft. Total building is approx 26K sq...read more
0 stars

RE:Covalon to show off MediClear products at Denver expo

Is this just SurgiClear with a new indication... I don't see why anyone would pay for this preop. every OR or ER set up includes Chloraprep. This will be an uphill battle in the cost containment...read more
0 stars

RE:RE:Covalon to show off MediClear products at Denver expo

Well now we know why they're looking for a marketing / graphic design coordinator; that promotional video is pretty bad.  Their older videos for ColActive and SurgiClear are much more professional...read more
0 stars

RE:Covalon to show off MediClear products at Denver expo

Promotional video on MediClear https://www.youtube.com/watch?v=GRSQ8CWjMls&feature=youtu.be  rate and reply
0 stars

Covalon to show off MediClear products at Denver expo

2015-03-06 15:27 ET - News Release Mr. John Hands reports COVALON TO INTRODUCE MEDICLEAR PRODUCT LINE AT AORN Covalon Technologies Ltd. is introducing its new MediClear product line, designed to...read more
0 stars

RE:Expansion of their leased space

I saw that. Despite the small quarterly losses which speculative investors seem to focus on, the long term seems to be about growth. More people being hired, more spaced being leased, more products...read more
0 stars

Expansion of their leased space

Did you notice in the MD&A that the company is will be leasing a second building beginning in June 2015? The second building is more expensive than their current space, so it looks like this could be...read more
5 stars

more hiring - marketing/graphic design coordinator

As per last Q reports they are hiring more people as business grows...here's another one https://ca.linkedin.com/jobs2/view/32098126?trk=jserp_job_details_text As a Marketing/Graphic Design...read more
0 stars

Q1 Yet another loss…

Another Quarter published another loss.  rate and reply
0 stars

Q1 Results

MISSISSAUGA, ON, Feb. 27, 2015 /CNW/ - Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV), an advanced medical technologies company, today announced financial results for its first...read more
0 stars

RE:Superbug cases spur FDA warning on dirty medical scopes

Zen; Total BS! There is no way the Covalon coating will ever be used on scopes... their coating is based is quasi hydrogel coating which would never stand up to the demands of scopes and repeated...read more
0 stars

Superbug cases spur FDA warning on dirty medical scopes

Does anyone know a company with an antimicrobial coating technology that could be applied to these devices?   Covalon Coatings Superbug cases spur FDA warning on dirty medical scopes Does anyone...read more
0 stars

RE:Heavy accumulation @ $1.50

So much for 1.50:(  rate and reply